{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-025322","form_type":"8-K/A","ticker":"CCCC","cik":"0001662579","company_name":"C4 Therapeutics, Inc.","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.576181+00:00","generated_at":"2026-06-23T08:02:21.697121+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"C4 Therapeutics board adopts annual advisory vote on exec compensation after stockholder recommendation","bullets":["Stockholders voted in favor of a 1-year frequency for advisory votes on named executive officer compensation.","Board determined to hold annual non-binding advisory votes until the next required frequency proposal.","Amendment filed solely to disclose this frequency decision; original 8-K reported June 22, 2022 annual meeting results."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-025322","json":"https://secwatch.observer/filing/0001628280-22-025322.json","markdown":"https://secwatch.observer/filing/0001628280-22-025322.md","text":"https://secwatch.observer/filing/0001628280-22-025322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/0001628280-22-025322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/cccc-20220622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:02:21.697121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}